Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket

Gainers

• Provention Bio, Inc. (NASDAQ:PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of approximately $2.9 billion.
• Tenax Therapeutics, Inc. (NASDAQ:TENX) rose 35.8% to $0.7737 in pre-market trading after gaining 23% on Friday.
• TRxADE HEALTH, Inc. (NASDAQ:MEDS) rose 15.9% to $0.40 in pre-market trading after dropping more than 5% on Friday.
• Meten Holding Group Ltd. (NASDAQ:METX) shares rose 15.5% to $0.2620 in pre-market trading.
• Myomo, Inc. (NYSE:MYO) rose 14.4% to $0.8471 in pre-market trading. Myomo is expected to report financial results for the three months and year ended Dec. 31, 2022 today.
• ObsEva SA (NASDAQ:OBSV) shares rose 13.8% to $0.1467 in pre-market trading after the company issued an update towards its strategic reorganization to consolidate operations in Switzerland.
• MicroStrategy Incorporated (NASDAQ:MSTR) shares rose 9.3% to $209.87 in pre-market trading after dropping 9% on Friday.
• Marathon Digital Holdings, Inc. (NASDAQ:MARA) rose 9% to $5.81 in pre-market trading.
• Riot Platforms, Inc. (NASDAQ:RIOT) rose 6.6% to $5.65 in pre-market trading after declining over 4% on Friday.
• ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rose 5.4% to $21.46 in pre-market trading after the company reported the FDA approval of DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients two years of age and older.

Losers

• First Republic Bank (NYSE:FRC) fell 54.7% to $37.01 in pre-market after the bank announced Sunday, that it enhanced its financial position through access to additional liquidity from the Fed and JPMorgan.
• GlycoMimetics, Inc. (NASDAQ:GLYC) fell 15.3% to $1.11 in pre-market trading.
• Cingulate Inc. (NASDAQ:CING) shares fell 15.1% to $1.57 in pre-market trading after posting a wider-than-expected quarterly loss.
• Altamira Therapeutics Ltd. (NASDAQ:CYTO) fell 12.8% to $1.36 in pre-market trading after jumping over 20% on Friday. Altamira Therapeutics, last week, filed for offering 3.2 million of common shares on a firm commitment basis.
• Laser Photonics Corporation (NASDAQ:LASE) fell 12.7% to $3.50 in pre-market trading. The company recently reported the expansion of its Service Partner Network (SPN) program.
• Cazoo Group Ltd (NYSE:CZOO) fell 12.4% to $2.29 in pre-market trading after jumping over 32% on Friday.
• Western Alliance Bancorporation (NYSE:WAL) shares dropped 12.4% to $43.20 in pre-market trading after dipping more than 20% on Friday.
• Molecular Templates, Inc. (NASDAQ:MTEM) fell 9% to $0.46 in pre-market trading after gaining over 7% on Friday. Molecular Templates, last week, received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program.
• Siyata Mobile Inc. (NASDAQ:SYTA) shares fell 7.9% to $0.2210 in pre-market trading.
• Hyperfine, Inc. (NASDAQ:HYPR) fell 7.3% to $1.40 in pre-market trading after declining 9% on Friday. Hyperfine is expected to report financial results for the fourth quarter on March 21, 2023.

Now Read This: Insiders Selling Perrigo And 3 Other Stocks